| Not Yet Recruiting | Esomeprazole Plus Sucralfate for Post-ESD Ulcer Healing NCT07312370 | LanZhou University | Phase 4 |
| Recruiting | Compare and Evaluate the Safety and PK Data of a Single Dose Administration of 'AD-115A' or 'AD-1151' NCT07385235 | Addpharma Inc. | Phase 1 |
| Recruiting | A Cohort Study of Mobile Capsule Gastroscopy for Gastric Pathologies Screening NCT07032961 | Nanfang Hospital, Southern Medical University | — |
| Completed | The Study Compare and Evaluate the Safety and PK Data of a Single Dose Administration of 'AD-115A' or 'AD-1151 NCT06902818 | Addpharma Inc. | Phase 1 |
| Recruiting | Capsule Gastric Endoscopy for Gastric Disease Screening in Simulated Home Scenarios NCT06848400 | Nanfang Hospital, Southern Medical University | N/A |
| Completed | Study to Evaluate the Bioequivalence of Vonopzan Tablet 20mg(Vonoprazan Fumarate) and Vocinti Tablet 20mg in H NCT06642987 | Hanlim Pharm. Co., Ltd. | Phase 1 |
| Completed | A Study to Evaluate the Effiacy and Safety of HIP0612 in Patients With Gastric Ulcer NCT05656092 | Hanmi Pharmaceutical Company Limited | Phase 3 |
| Terminated | Systems Biology of Gastrointestinal and Related Diseases NCT05579444 | Viome | — |
| Unknown | Dose Exploration of Ciprofol for Sedation in Gastrointestinal Endoscopic Diagnosis and Treatment of Obese Pati NCT05517408 | RenJi Hospital | N/A |
| Completed | Clinical Trial to Evaluate the Efficacy and Safety of JP-1366 in Patients With Gastric Ulcer NCT05448001 | Onconic Therapeutics Inc. | Phase 3 |
| Completed | Hypoxia During Gastroenterological Endoscope Procedures Sedated With Ciprofol In Overweight Or Obesity Patient NCT05518929 | RenJi Hospital | Phase 4 |
| Recruiting | Raman Spectroscopy-Based Deep Learning Model for Early Pan-Cancer Early Diagnosis NCT06822413 | Second Affiliated Hospital, School of Medicine, Zhejiang University | — |
| Unknown | HFNO Combined With NPA Reduces Hypoxia During Sedated Gastrointestinal Endoscopy In Obese Patients NCT05526339 | RenJi Hospital | N/A |
| Completed | Understanding Ayurveda Disease Conditions and Treatment Responses NCT06167226 | Ayurai Private Limited | — |
| Unknown | Compare the Effect of Eupatilin and Rebamipide on the Prevention of Gastroenteropathy NCT04885751 | Seoul National University Boramae Hospital | Phase 4 |
| Completed | MAGNET (Magnetically Controlled Capsule for Assessment of Gastric Mucosa in Symptomatic Patients) NCT04724291 | George Washington University | N/A |
| Recruiting | Samples Procurement for Colorectal Cancer, Gastric Cancer, and Non-malignant Disease NCT03972956 | Renmin Hospital of Wuhan University | — |
| Completed | Helicobacter Rescue Therapy With Berberine Plus Amoxicillin Quadruple Therapy Versus Tetracycline Plus Furazol NCT03609892 | Xijing Hospital of Digestive Diseases | Phase 4 |
| Completed | A Study of Esomeplazole (D961H) in Japanese Paediatric Patients With Reflux Esophagitis, Gastric Ulcer or Duod NCT03553563 | AstraZeneca | Phase 3 |
| Completed | Comparison Between Two Types of Sedation for Elective Upper Endoscopy Procedures NCT04410211 | University of Malaya | N/A |
| Completed | To Compare the Gastrointestinal Safety of a 14-Day Oral Dosing Regimen of ATB-346 to Sodium Naproxen in Health NCT03291418 | Antibe Therapeutics Inc. | Phase 1 / Phase 2 |
| Completed | Comparison of TAK-438 (Vonoprazan) to Lansoprazole in the Treatment of Gastric Ulcer Participants With or With NCT03050307 | Takeda | Phase 3 |
| Completed | Helicobacter Pylori Sample Collection Protocol Pre Therapy Subjects NCT03060746 | DiaSorin Inc. | — |
| Completed | Helicobacter Pylori Sample Collection Protocol Post Therapy Subjects NCT03060733 | DiaSorin Inc. | — |
| Completed | Study to Evaluate the Safety and Efficacy of CJ-12420 in Patients With Gastric Ulcer NCT02761512 | HK inno.N Corporation | Phase 3 |
| Completed | A Study to Compare the Pharmacokinetics of Lafutidine and Irsogladine Maleate Tablet NCT02759224 | Boryung Pharmaceutical Co., Ltd | Phase 1 |
| Unknown | A Multi-center Study for Individual Treatment of Helicobacter Pylori Infection NCT02689583 | First Affiliated Hospital of Zhejiang University | N/A |
| Unknown | A Study on the Gastrointestinal Disease and Helicobacter Pylori Controlled Long Non-coding RNA NCT03057171 | Yonsei University | — |
| Completed | Rabeprazole Specific Clinical Experience Investigation for the Long-term Combination Therapy With Low-dose Asp NCT02423187 | Eisai Co., Ltd. | — |
| Completed | Magnetic-controlled Capsule Endoscopy vs. Gastroscopy for Detection of Gastric Diseases NCT02219529 | Changhai Hospital | Phase 3 |
| Completed | BE Study Between a Capsule and a Sachet Formulation of D961H by Pharmacodynamics in Japanese Healthy Male Subj NCT01964131 | AstraZeneca | Phase 1 |
| Unknown | Remote-controlled Capsule Endoscopy: a Feasibility Study NCT01946633 | Nanfang Hospital, Southern Medical University | N/A |
| Completed | Nexium Capsules LDA Specific Clinical Experience Investigation NCT01729182 | AstraZeneca | — |
| Completed | A Clinical Trial to Investigate the Safety, Tolerability, Pharmacokinetics, and Food Effect of PMK-S005 After NCT01762397 | PharmaKing | Phase 1 |
| Completed | A Unblinded Study of TAK-438 (20 mg) for Prevention of Recurrence of Gastric or Duodenal Ulcer During Long-Ter NCT01568398 | Takeda | Phase 3 |
| Completed | Nexium Capsules Non-steroidal Anti-inflammatory Drug (NSAID) Specific Clinical Experience Investigation NCT01562600 | AstraZeneca | — |
| Completed | A Unblinded Study of TAK-438 (20 mg) for Prevention of Recurrence of Gastric or Duodenal Ulcer During Long-Ter NCT01568385 | Takeda | Phase 3 |
| Completed | Efficacy of TAK-438 Compared to AG-1749 (Lansoprazole) in the Treatment of Gastric Ulcer NCT01452711 | Takeda | Phase 3 |
| Completed | Nexium Capsules Helicobacter Pylori Specific Clinical Experience Investigation NCT01435525 | AstraZeneca | — |
| Completed | Mucosta in Gastric Ulcer Treatment, Effectiveness and Safety Evaluation NCT01150162 | Otsuka Pakistan Limited | Phase 3 |
| Completed | Efficacy and Safety of Teprenone in Patients With Acute Gastritis, Acute Gastric Lesion of Chronic Gastritis W NCT01190657 | Eisai Co., Ltd. | Phase 4 |
| Completed | Study to Evaluate the Incidence of Gastric Ulcers Following Administration of Either PA32540 or Enteric Coated NCT00960869 | POZEN | Phase 3 |
| Unknown | Comparison of Ulcer Healing in Patients Taking Rabeprazole With Different Antiplatelets NCT01037491 | Taipei Veterans General Hospital, Taiwan | N/A |
| Completed | A Study to Evaluate the Incidence of Gastric Ulcers Following Administration of Either PA32540 or Enteric Coat NCT00961350 | POZEN | Phase 3 |
| Completed | Long Term Study to Investigate the Efficacy & Safety of D961H (Esomeprazole) for the Prevention of NSAIDs-indu NCT00595517 | AstraZeneca | Phase 3 |
| Completed | Evaluating PN 400 (VIMOVO) in Reducing Gastric Ulcers Compared to Non-steroidal Antiinflammatory Drug (NSAID) NCT01129011 | POZEN | Phase 3 |
| Completed | Evaluating PN 400 (VIMOVO) in Reducing Gastric Ulcers Compared to Non-steroidal Antiinflammatory Drug (NSAID) NCT00527787 | POZEN | Phase 3 |
| Terminated | Evaluating PN 400 (VIMOVO) in Reducing Gastric Ulcers in High Risk Subjects Compared to Arthrotec NCT00594854 | POZEN | Phase 3 |
| Completed | Comparative Efficacy & Safety Study of Esomeprazole Versus Placebo for the Prevention of Gastric and Duodenal NCT00542789 | AstraZeneca | Phase 3 |
| Completed | A 12-month, Phase 3, Open-label, Multi-center Study to Evaluate the Long-term Safety of PN400 (VIMOVO) NCT00527904 | POZEN | Phase 3 |
| Completed | Study of Esomeprazole 20 mg or 40 mg vs Placebo Effectiveness on the Occurrence of Peptic Ulcers in Subjects o NCT00441727 | AstraZeneca | Phase 3 |
| Completed | An Open-label, Exploratory Trial to Assess Gastric Acid Control in Critically Ill Subjects Receiving Nexium NCT00428701 | AstraZeneca | Phase 4 |
| Completed | Efficacy and Safety Study of Esomeprazole 20mg qd vs Ranitidine 150mg Bid in Patients With an NSAID-induced Ga NCT00401752 | AstraZeneca | Phase 3 |
| Unknown | Second Line Therapy for the Cure of Helicobacter Pylori (H. Pylori) Infection NCT00197418 | Hamamatsu University | Phase 2 / Phase 3 |
| Unknown | Tailored Treatment of H. Pylori Infection Based Polymorphisms of CYP2C19 and 23S rRNA of H. Pylori NCT00149084 | Hamamatsu University | Phase 3 |
| Completed | Pepsinogens as the Early Marker of H. Pylori Eradication NCT00197457 | Hamamatsu University | Phase 2 |
| Completed | Effect of Selective COX-2 Inhibition on Ulcer Healing NCT00153673 | Chinese University of Hong Kong | Phase 3 |
| Completed | Helicobacter Pylori Eradication With a New Sequential Treatment NCT00132171 | IRCCS Azienda Ospedaliero-Universitaria di Bologna | Phase 3 |
| Completed | Lymphocytic Subsets and Cytokine Production With H. Pylori Infection NCT00173953 | National Taiwan University Hospital | N/A |
| Unknown | Cytokine Gene Polymorphisms in Gastric Diseases NCT00197470 | Hamamatsu University | N/A |
| Terminated | Safety of Rabeprazole in Patients Under Multiple Treatments NCT00511745 | Janssen-Cilag, S.A. | — |